Rusalatide acetate (TP508 amide acetate), a regenerative peptide, mitigates radiation-induced gastrointestinal damage by activating stem cells and preserving crypt integrity.
CAT No: R1662
CAS No: 875455-82-6
Synonyms/Alias: Chrysalin;Rusalatide acetate;875455-82-6;Rusalatide acetate [USAN];TP508;TRAP 508;UNII-9J556O9JPD;9J556O9JPD;TP 508;TRAP-508;Rusalatide acetate (USAN);TP508 amide acetate;TP-508 ACETATE;TRAP-508 ACETATE;Rusalatide acetate (3:2);L-Valinamide, L-alanylglycyl-L-tyrosyl-L-lysyl-L-prolyl-L-alpha-aspartyl-L-alpha- glutamylglycyl-L-lysyl-L-arginylglycyl-L-alpha-aspartyl-L-alanyl-L-cysteinyl-L-alpha- glutamylglycyl-L-alpha-aspartyl-L-serylglycylglycyl-L-prolyl-L-phenylalanyl-, acetate (3:2) (salt);Chrysalin (TN);RUSALATIDE ACETATE (3:2) [MI];DA-77590;ALA-GLY-TYR-LYS-PRO-ASP-GLU-GLY-LYS-ARG-GLY-ASP-ALA-CYS-GLU-GLY-ASP-SER-GLY-GLY-PRO-PHE-VAL ACETATE;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C295H449N87O109S3 |
M.W/Mr. | 7054 |
Sequence | Three Letter Code:H-Ala-Gly-Tyr-Lys-Pro-Asp-Glu-Gly-Lys-Arg-Gly-Asp-Ala-Cys-Glu-Gly-Asp-Ser-Gly-Gly-Pro-Phe-Val-NH2.H-Ala-Gly-Tyr-Lys-Pro-Asp-Glu-Gly-Lys-Arg-Gly-Asp-Ala-Cys-Glu-Gly-Asp-Ser-Gly-Gly-Pro-Phe-Val-NH2.H-Ala-Gly-Tyr-Lys-Pro-Asp-Glu-Gly-Lys-Arg-Gly-Asp-Ala-Cys-Glu-Gly-Asp-Ser-Gly-Gly-Pro-Phe-Val-NH2.2CH3CO2H |
InChI | InChI=1S/3C97H147N29O35S.2C2H4O2/c3*1-48(2)79(80(101)145)124-92(157)60(35-51-15-6-5-7-16-51)120-94(159)66-20-13-33-125(66)73(134)45-105-68(129)40-107-86(151)64(46-127)122-90(155)62(38-77(141)142)115-72(133)44-110-85(150)57(27-29-75(137)138)118-93(158)65(47-162)123-82(147)50(4)111-88(153)61(37-76(139)140)114-71(132)43-108-83(148)54(19-12-32-104-97(102)103)116-87(152)55(17-8-10-30-98)112-69(130)42-109-84(149)56(26-28-74(135)136)117-91(156)63(39-78(143)144)121-95(160)67-21-14-34-126(67)96(161)58(18-9-11-31-99)119-89(154)59(36-52-22-24-53(128)25-23-52)113-70(131)41-106-81(146)49(3)100;2*1-2(3)4/h3*5-7,15-16,22-25,48-50,54-67,79,127-128,162H,8-14,17-21,26-47,98-100H2,1-4H3,(H2,101,145)(H,105,129)(H,106,146)(H,107,151)(H,108,148)(H,109,149)(H,110,150)(H,111,153)(H,112,130)(H,113,131)(H,114,132)(H,115,133)(H,116,152)(H,117,156)(H,118,158)(H,119,154)(H,120,159)(H,121,160)(H,122,155)(H,123,147)(H,124,157)(H,135,136)(H,137,138)(H,139,140)(H,141,142)(H,143,144)(H4,102,103,104);2*1H3,(H,3,4)/t3*49-,50-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,79-;;/m000../s1 |
InChI Key | AHMIRVCNZZUANP-LPBAWZRYSA-N |
2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.